According to Marksans Pharma
's latest financial reports the company has โน23.75 Billion in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2024-03-31 | $โน20.85 B | 18.18% |
2023-03-31 | $โน17.65 B | 44.33% |
2022-03-31 | $โน12.22 B | 35.08% |
2021-03-31 | $โน9.05 B | 39.47% |
2020-03-31 | $โน6.49 B | 17.45% |
2019-03-31 | $โน5.52 B | 15.05% |
2018-03-31 | $โน4.80 B | 9.26% |
2017-03-31 | $โน4.39 B | -2.99% |
2016-03-31 | $โน4.53 B | 16.86% |
2015-03-31 | $โน3.87 B | 160.63% |
2014-03-31 | $โน1.48 B | 59.22% |
2013-03-31 | $โน0.93 B | -157.53% |
2012-03-31 | $-โน1.63 Billion | 159.48% |
2011-03-31 | $-โน0.63 Billion | -138.65% |
2010-03-31 | $โน1.62 B | 7.31% |
2009-03-31 | $โน1.50 B | 6.23% |
2008-03-31 | $โน1.42 B | 12.45% |
2007-03-31 | $โน1.26 B | 5.64% |
2006-03-31 | $โน1.19 B | 16.94% |
2005-03-31 | $โน1.02 B |